Skip to Main Content

President Trump’s proposed budget for 2018, rife with deep cuts including a 20 percent funding reduction for the National Institutes of Health, has been greeted with a chorus of dismay from biopharma scientists and executives.

Talia Bronshtein/STAT Source: GPO: Budget of the United States Government

Consider the words used by industry veterans interviewed by STAT: “Pretty horrifying.” “A tragedy.” “Appalling.” “Incredibly short-sighted.” (One exception was the drug industry’s top lobbying group PhRMA, which put out a statement that … didn’t say much of anything.)

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!